16 hours ago
The application, submitted by Merck, is based on data from 2 clinical trials evaluating patients with refractory or unexplained chronic cough.
February 28, 2021
From better education, to remote monitoring and consistent check-ins, clinicians may need to initiate better adherence in their younger, severely ill patients.
February 28, 2021
How dupilumab is observed to benefit EoE patients—and who may administer the biologic therapy.
February 28, 2021
An interview on the TSLP inhibitor's effect on exacerbations, hospitalizations, and disease progress over 52-week findings.
February 28, 2021
In data presented during AAAAI 21, researchers compared the 2006 and 216 versions of the diagnostic criteria proposed by the NIAD/FAAN.